Video Experimental Relacionado
Updated: Jan 8, 2026
07:59
Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
Published on: September 8, 2023
1.6K
Alteraciones Genéticas en el CPNM: Implicaciones Pronósticas e Impacto en la Resistencia Terapéutica
Bhardwaj Tina Neelesh1, Kanchan Bhardwaj1, Phani Mn2
1Manav Rachna International Institute of Research and Studies, Faridabad, Haryana.
American journal of clinical oncology
|December 23, 2025
Resumen
El cáncer de pulmón no microcítico (CPNM) es un cáncer común con cambios genéticos complejos. Comprender estas alteraciones moleculares es clave para desarrollar tratamientos efectivos y mejorar los resultados de los pacientes.
Área de la Ciencia:
- Oncología
- Biología Molecular
- Genética
Sus antecedentes:
- La incidencia del cáncer de pulmón está aumentando a nivel mundial, y el cáncer de pulmón no microcítico (CPNM) representa aproximadamente el 85% de los casos.
- El manejo actual del CPNM enfrenta desafíos debido a una comprensión incompleta de sus mecanismos moleculares.
- Los tumores exhiben complejas interacciones genéticas que influyen en el crecimiento, la metástasis y la respuesta terapéutica.
Objetivo del estudio:
- Revisar las alteraciones genéticas y epigenéticas establecidas en el CPNM.
- Destacar la importancia de comprender la patogénesis molecular para mejorar la atención al paciente.
- Analizar la necesidad de identificar alteraciones genéticas para guiar el desarrollo de la terapia.
Principales métodos:
- Revisión de la literatura sobre alteraciones genéticas y epigenéticas establecidas en el CPNM.
- Análisis del impacto de los cambios genéticos en el comportamiento tumoral y la respuesta al tratamiento.
- Discusión del papel de la genotipación molecular en la estratificación de pacientes y la planificación del tratamiento.
Principales resultados:
- Los tumores de CPNM albergan múltiples cambios genéticos interactivos.
- Las alteraciones genéticas influyen en el crecimiento tumoral, el potencial metastásico y la resistencia a los fármacos.
- La identificación de alteraciones específicas puede predecir la respuesta al tratamiento y la resistencia.
Conclusiones:
- Una comprensión integral de la patogénesis molecular del CPNM es crucial.
- La identificación de alteraciones genéticas ayuda a anticipar la resistencia y a desarrollar terapias combinadas.
- La genotipación molecular permite estrategias de tratamiento personalizadas y un mejor diseño de ensayos clínicos.
Más Videos Relacionados
08:52Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids
Published on: November 22, 2021
4.5K
08:46Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
11.1K
Videos de Conceptos Relacionados
02:56Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
02:57Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
02:50Combination Therapies and Personalized Medicine
5.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.8K
02:53Adaptive Mechanisms in Cancer Cells
6.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.9K
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
9.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.3K
01:33Cancer-Critical Genes I: Proto-oncogenes
11.1K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
11.1K